The Food and Drug Administration (FDA) announced Wednesday plans to help states and Indian tribes import cheaper prescription drugs from Canada. The initiative is in support of President Donald Trump’s executive order on May 12 which promised to deliver “most-favored nation prescription drug pricing” to America,

FDA Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad set stricter approval standards for booster shots

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy

Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults.

The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.

Dr. Raynard Washington, epidemiologist and health director in Mecklenburg County, North Carolina, discusses new guidelines from the FDA.

Michael Rogers, a top official at the Food and Drug Administration, announced Monday he is retiring amid the Trump administration’s mission to revamp the agency. Rogers, who ​​oversees the FDA’s drug and food safety inspections,

Health and Human Services employees were told in March to remove 'nicknames' from email systems and signatures to comply with Trump order on gender.

A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human Services Secretary Robert F. Kennedy Jr.

The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must do to seek approval of vaccines, a move that comes as the Trump administration has introduced uncertainty into the annual process for green-lighting updated coronavirus shots traditionally offered in the fall.